ArticleLasers in medical science2025
Ten-year outcomes of effective optical zone and decentration analysis after keratorefractive lenticule extraction for moderate and high myopia.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To investigate ten-year changes in the effective optical zone (EOZ) and decentration after keratorefractive lenticule extraction (KLEx) for moderate and high myopia. In this prospective study, 27 patients (48 eyes, spherical equivalent: -6.34 ± 1.19 D) were enrolled and treated with KLEx. Follow-up was conducted 10 years postoperatively. The EOZ and decentration were calculated using custom software based on the tangential corneal curvature maps. The relationships among keratometry, corneal wavefront aberrations, EOZ, and decentration were evaluated. Ten years postoperatively, the safety and efficacy indexes were 1.14 ± 0.19 and 1.05 ± 0.25, respectively. The EOZ diameter was 5.31 ± 0.26 mm. In the longitudinal analysis, the percentages of (1-EOZ/POZ) were 31.02 ± 1.02%, 31.14 ± 1.08%, 33.22 ± 1.06%, and 34.91 ± 1.02% at postoperative 1 month, 1 year, 5 years, and 10 years. The differences between preoperative and postoperative higher-order aberrations (HOAs) were 0.23 ± 0.02 μm, 0.24 ± 0.02 μm, 0.21 ± 0.02 μm, 0.17 ± 0.02 μm. The factors influencing the EOZ percentages were time (p = 0.002), correction cylinders (p = 0.005), and interaction between correction cylinders and spheres (p = 0.014), and the factors influencing HOAs inductions were time (p = 0.001), scotopic pupil (p = 0.001), postoperative decentration (p < 0.001), EOZ diameter (p = 0.030), and the interaction between decentration and EOZ diameter (p = 0.002). The decentration was 0.39 ± 0.15 mm at the last follow-up, which was statistically unchanged throughout the follow-up. KLEx is safe and effective for patients with moderate or high myopia in the long term. The EOZ decreased slightly but was broadly stable, and the decentration remained stable during the 10-year follow-up.
Indexed as
Identifiers
40512302What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.